Belgium· BE-AMP-SAM325367-00

Nogest 5 mg

A nomegestrol product containing nomegestrol acetate, registered in Belgium by Ceres Pharma. The same ATC class is registered in 3 of our 19 countries.

ATC G03DB04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedNogest 5 mgATCG03DB04REGISTER NO.BE-AMP-SAM325367-00PACKS LISTED5CHECKEDSeptember 26, 2026

Where it is registered

Nomegestrol is registered in 3 of 19 countries.

Countries holding a registration under ATC G03DB04 (nomegestrol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 3 of them publish a price we can compare per daily dose

Nomegestrol · ATC G03DB04

3 / 19 countries

  • Belgiumprice
  • Franceprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Nomegestrol Acetate
Manufacturer
Ceres Pharma
Country
Belgium (BE)
ATC code
G03DB04
ATC class
Nomegestrol
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 5

1 priced
  • be_apb
    2565471
    EUR 19.76
  • be_apb
    2584092
  • be_apb
    2550556
  • be_apb
    0792226
  • be_apb
    2565463

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Nomegestrol in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nomegestrol products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • France · Lutenyl, Nomegestrol Eg
  • Italy · Lutenyl
  • Luxembourg · Lutenyl
  • Poland · Lutenyl
  • Portugal · Lutenyl

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/776db71a-c750-4b0a-a1e5-b07597351585
GET /v1/drugs/776db71a-c750-4b0a-a1e5-b07597351585?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Nogest 5 mg",
  "name_fr": "Nogest 5 mg",
  "name_nl": "Nogest 5 mg",
  "amp_code": "SAM325367-00",
  "strengths": [
    "5.0000",
    "5.0000",
    "120.9900"
  ],
  "pack_count": 6,
  "substances": [
    "Nomegestrol Acetate",
    "Lactose Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Nomegestrol",
  "authorisation_numbers": [
    "BE325367"
  ]
}

See everything about nomegestrol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.